Home | Articles
Published on:January 2022
Indian Journal of Pharmaceutical Education and Research, 2022; 56(1):287-295
Original Article | doi:10.5530/ijper.56.1.34

Establishment of a Rapid and Highly Sensitive Reverse-phase High-performance Liquid Chromatography Based Analytical Assay Method for Duvelisib


Authors and affiliation (s):

Dipali Sonawane, Amit Kumar Sahu, Tarang Jadav, Pinaki Sengupta*

National Institute of Pharmaceutical Education and Research-Ahmedabad (NIPER-A), an Institute of National Importance, Government of India, Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Gandhinagar, Gujarat, INDIA.

Abstract:

Background: Duvelisib is an antineoplastic agent that received global approval from the United States Food and Drug Administration in 2018. An extensive literature search revealed that analytical method for the quantification of duvelisib at nanogram level is not available till date. A highly sensitive analytical method is necessary to analyze diversified samples containing trace levels of the analyte such as dissolution samples of sustained release formulation, cross-contamination study samples etc. Materials and Methods: Primary aim of this research was to develop a high throughput, accurate, reproducible, and highly sensitive high performance liquid chromatography method for quantification of duvelisib and validate according to the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use and Association of Official Analytical Collaboration guidelines. Results: A linear relationship was confirmed over 70 to 5000 ng/mL concentrations with a limit of detection value of 20 ng/mL. The intra and inter-day precision were found to be 0.97 to 1.87% and 1.25 to 1.99%, respectively. Conclusion: This is the first time to report a quantitative assay method for duvelisib, which can quantify the analyte even at the nanogram level. This method will be suitable for sample analysis of quality control, stability, cross-contamination, dissolution study of sustained-release formulation and effluent analysis of duvelisib in pharmaceutical industries and research laboratories.

Key words: Duvelisib, HPLC, Analytical assay method, Development, Validation.

 




 

Impact Factor

IJPER - An Official Publication of Association of Pharmaceutical Teachers of India is pleased to announce continued growth in the Latest Release of Journal Citation Reports (source: Web of Science Data).

 

Impact Factor® as reported in the 2021 Journal Citation Reports® (Clarivate Analytics, 2022): 0.843

The Official Journal of Association of Pharmaceutical Teachers of India (APTI)
(Registered under Registration of Societies Act XXI of 1860 No. 122 of 1966-1967, Lucknow)

Indian Journal of Pharmaceutical Education and Research (IJPER) [ISSN-0019-5464] is the official journal of Association of Pharmaceutical Teachers of India (APTI) and is being published since 1967.

DOI HISTORY

IJPER uses reference linking service using Digital Object Identifiers (DOI) by Crossref. Articles from the year 2013 are being assigned DOIs for its permanent URLs